RxDoctor Payments Data

Ivan Morris, DO

Family Medicine · East Lansing, MINPI 1760757561

Payments from drug & device makers

$14,213in general payments, 2019–2025

Across 1,000 payments — averaging $14.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$2K
  • Amgen$1K
  • Pfizer$1K
  • AstraZeneca$896
  • Lilly USA, LLC$788
  • plus $5K from 54 others

What the payments were for

  • Food & beverage$14,213100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk152$2,090
AbbVie(2 entities)173$1,927
Amgen(2 entities)140$1,482
Pfizer86$1,407
AstraZeneca40$896
Lilly USA, LLC59$788
GSK37$418
Boehringer Ingelheim21$411
Takeda Pharmaceuticals U.S.A., Inc.24$396
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)19$269
Averitas Pharma Inc.14$248
Merck13$241
Bayer15$239
Teva Pharmaceuticals USA, Inc.21$227
Amarin Pharma, Inc.10$175
Johnson & Johnson(2 entities)9$159
GRT US Holding, Inc.10$155
Biohaven Pharmaceutical Holding Company Ltd.8$144
Xeris Pharmaceuticals, Inc.7$131
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC8$123
Biohaven Pharmaceuticals, Inc.11$122
Axsome Therapeutics, Inc.5$118
Sanofi-aventis U.S. LLC6$109
Exact Sciences6$101
Seqirus USA Inc5$96
Astellas Pharma US Inc5$93
Novartis5$84
Otsuka America Pharmaceutical, Inc.4$76
Supernus Pharmaceuticals, Inc.4$70
Antares Pharma, Inc.5$69
Radius Health, Inc.3$68
Paratek Pharmaceuticals, Inc.4$63
Jazz Pharmaceuticals Inc.4$63
Eisai Inc.4$62
UCB, Inc.1$54
Madrigal Pharmaceuticals3$53
Boston Scientific3$52
Lundbeck LLC3$49
Bioventus LLC3$47
Gilead3$47
Neurelis, Inc.3$44
Bardy Diagnostics, Inc.3$43
Sanofi Pasteur Inc.2$42
Dynavax Technologies Corporation4$39
Vanda Pharmaceuticals Inc.1$37
Nestle Healthcare Nutrition Inc.2$36
Fidia Pharma USA Inc.2$35
Idorsia Pharmaceuticals US Inc2$35
Corium, LLC2$34
Ardelyx, Inc.2$32
Halozyme Inc2$32
Currax Pharmaceuticals LLC2$32
E.r. Squibb & Sons, L.L.C.1$28
Verity Pharmaceuticals Inc.1$26
Viatris Specialty LLC1$25
Melinta Therapeutics, LLC1$24
Aimmune Therapeutics, Inc.1$24
Phadia US Inc.1$20
Mylan Specialty L.p.1$19
Corcept Therapeutics1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,213 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$76,283
Medicare patients
258
Services billed
1,402

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide63$76,123
EliquisApixaban50$65,954
TrulicityDulaglutide19$41,140
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44$38,969
MounjaroTirzepatide30$38,735
FarxigaDapagliflozin Propanediol26$28,000
JanuviaSitagliptin Phosphate24$27,655
JardianceEmpagliflozin24$24,782
RybelsusSemaglutide16$20,363
Tresiba Flextouch U-100Insulin Degludec17$16,434
Testosterone23$11,930
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$8,198
LinzessLinaclotide14$7,289
ArexvyRsvpref3 Antigen/As01e/Pf17$5,447
PremarinEstrogens, Conjugated18$4,959

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$2,090$96,48679 claims
Lilly USA, LLCTrulicity, Mounjaro$788$79,87549 claims
PfizerEliquis, Premarin$1,407$70,91268 claims
GSKTrelegy Ellipta, Anoro Ellipta, Arexvy, Shingrix$418$57,11893 claims
AstraZenecaFarxiga$896$28,00026 claims
MerckJanuvia$241$27,65524 claims
Boehringer IngelheimJardiance$411$24,78224 claims
AbbVieLinzess$1,927$7,28914 claims
BayerClimara Pro$239$2,91212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in East Lansing

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →